Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study

BACKGROUND: Penile cancer (PC) is a rare tumor, and therapeutic options are limited for this disease, with an overall 5-year overall survival around 65-70%. Adjuvant therapy is not recommended for patients with N0-1 disease, despite up to 60% of these patients will die within 5 years from diagnosis....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Di Lorenzo, Giuseppe, Perdonà, Sisto, Buonerba, Carlo, Sonpavde, Guru, Gigantino, Vincenzo, Pannone, Giuseppe, Quarto, Giuseppe, Ferro, Matteo, Gaudioso, Gabriella, Terracciano, Daniela, Di Trolio, Rossella, Rescigno, Pasquale, Botti, Gerardo, De Placido, Sabino, Facchini, Gaetano, Ascierto, Paolo A, Franco, Renato
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3717121/
https://ncbi.nlm.nih.gov/pubmed/23819610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars